ARAY
Accuray Incorporated
NASDAQ · Healthcare · Medical - Devices · US
$0.27
+0.30%Year over year
Reported trailing growth
- Revenue
- -12.3%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +2.5%
- EBITDA
- +153.6%
- EPS
- +39.3%
Three-year CAGR
- Revenue
- -3.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026